BioAge Labs, Inc (BIOA) — Cash Flow-to-Debt Ratio
BioAge Labs, Inc (BIOA) has a Cash Flow-to-Debt Ratio of -0.58x as of September 2025, meaning its operating cash flow of $-16.04 Million could theoretically repay -1% of its total liabilities ($27.63 Million) in one year. Explore BioAge Labs, Inc (BIOA) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BioAge Labs, Inc Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for BioAge Labs, Inc across 8 annual periods. Also explore BioAge Labs, Inc (BIOA) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for BioAge Labs, Inc (2013–2024)
Year-by-year debt coverage analysis for BioAge Labs, Inc. For market capitalisation and broader financial context, see BIOA company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.47x | $-51.52 Million | $35.11 Million | ▼ -682.9% |
| 2023 | -0.19x | $-37.36 Million | $199.32 Million | ▲ +27.0% |
| 2022 | -0.26x | $-36.18 Million | $140.99 Million | ▲ +58.9% |
| 2017 | -0.63x | $-29.79 Million | $47.66 Million | ▼ -87.5% |
| 2016 | -0.33x | $-37.62 Million | $112.84 Million | ▼ -0.1% |
| 2015 | -0.33x | $-32.20 Million | $96.73 Million | ▼ -40.7% |
| 2014 | -0.24x | $-22.45 Million | $94.91 Million | ▲ +57.8% |
| 2013 | -0.56x | $-27.52 Million | $49.07 Million | — |